2022•The Brown University Psychopharmacology UpdateRequires access

Opioid use disorder treatments also improve stimulant use outcomes

Author information unavailable

Abstract

Bupropion and medications for opioid use disorder (OUD; methadone, buprenorphine, and naltrexone) both were found to improve stimulant‐related outcomes in a case‐crossover study of patients with OUD. These medications were associated with reduced stimulant‐related emergency department admissions and hospitalizations. Study results were published online June 20, 2022, in the Journal of Clinical Psychiatry.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Opioid use disorder, Stimulant, Buprenorphine, Medicine, Naltrexone, Bupropion, Opioid, Methadone